Showing 1351-1360 of 4730 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-42/23844/Honey for Recurrent Minor Aphthous Ulcers; Foundations for an Online Initiative
https://practicaldermatology.com/youngmd-connect/resident-resource-center/honey-for-recurrent-minor-aphthous-ulcers-foundations-for-an-online-initiative/20658/Filling Us In: A Global View of Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/filling-us-in-a-global-view-of-fillers/20469/A sneak peek at fillers heading for the US market.New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/22935/New in My Practice: Cosmeceuticals
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-cosmeceuticals-3/23826/Pearls for Choosing and Initiating Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0309_18-php/22872/Members of the psoriasis panel at the 2009 South Beach Symposium last month offered insights on patient care.Two Investment Options with Upside Potential and Downside Protection: Equity-indexed Life Policies and Structured Notes
https://practicaldermatology.com/topics/practice-management/two-investment-options-with-upside-potential-and-downside-protection-equity-indexed-life-policies-and-structured-notes/23332/Options provide valuable components of a physician’s overall portfolio.Subcutaneous Sarcoidosis Diagnosed in a 55-Year-Old Female
https://practicaldermatology.com/youngmd-connect/resident-resource-center/subcutaneous-sarcoidosis-diagnosed-in-a-55-year-old-female/22084/New in My Practice: Serum/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-serumnew-products/23888/GLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/The impact of glucagon-like peptide-1 agonists (GLP-1), such as semaglutide, tirzepatide and liraglutide, has transformed the healthcare industry and, in particular, aesthetic dermatology. The most common intended use of these medications, namely diabetes management and weight loss, can lead to a mu